A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases

European Journal of Immunology

Volumn 35, Issue 7, 2005, Pages 2239-2249

  Huang, Chiu Chen ^a   Lu, Yi Fen ^a   Wen, Shi Ni ^a   Hsieh, Wen Chuan ^a   Lin, Yu Chin ^a   Liu, Meng Ru ^a   Chiang, Evelyn ^a   Chang, Chung Nan ^a   Lin, Rong Hwa ^a  

^a AbGenomics Corporation   (Taiwan)

Author keywords

Antibodies; Apoptosis; Autoimmunity; Graft vs host disease; T lymphocytes

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TAB4; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BINDING SITES, ANTIBODY; BINDING, COMPETITIVE; CRICETINAE; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; P-SELECTIN; T-LYMPHOCYTES;

EID: 22544450760     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200525849     Document Type: Article

References (37)

1. Sigal, N. H. and Dumont, F. J., Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 1992. 10: 519-560.
2. Goldman, J. M., Gale, R. P., Horowitz, M. M., Biggs, J. C., Champlin, R. E., Gluckman, E., Hoffmann, R. G., Jacobsen, S. J., Marmont, A. M., McGlave, P. B. et al., Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T cell depletion. Ann. Intern. Med. 1988. 108: 806-814.
3. Cohen, J. J., Duke, R. C., Fadok, V. A. and Sellins, K. S., Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 1992. 10: 267-293.
4. Jo, M., Kim, T. H., Seol, D. W., Esplen, J. E., Dorko, K., Billiar, T. R. and Strom, S. C., Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat. Med. 2000. 6: 564-567.
5. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S., Lethal effect of the anti-Fas antibody in mice. Nature 1993. 364: 806-809.
6. Chen, S. C., Huang, C. C., Chien, C. L., Jeng, C. J., Su, H. T., Chiang, E., Liu, M. R., Wu, C. H., Chang, C. N. and Lin, R. H., Cross-linking of P-selectin glycoprotein ligand-1 induces death of activated T cells. Blood 2004. 104: 3233-3242.
7. Jones, A. T., Federsppiel, B., Ellies, L. G., Williams, M. J., Burgener, R., Duronio, V., Smith, C. A., Takei, F. and Ziltener, H. J., Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. J. Immunol. 1994. 153: 3426-3439.
8. Jung, T. M., Gallatin, W. M., Weissman, I. L. and Dailey, M. O., Down-regulation of homing receptors after T cell activation. J. Immunol. 1988. 141: 4110-4117.
9. Sprent, J. and Tough, D. F., Lymphocyte life-span and memory. Science 1994. 265: 1395-1400.
10. Anasetti, C., Martin, P. J., Storb, R., Appelbaum, F. R., Beatty, P. G., Davis, J., Doney, K., Hill, H. F., Stewart, P., Sullivan, K. M. et al., Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation 1992. 54: 844-851.
11. Blazar, B. R., Taylor, P. A. and Vallera, D. A., In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice. J. Immunol. 1994. 152: 3665-3674.
12. Prentice, H. G., Blacklock, H. A., Janossy, G., Bradstock, K. F., Skeggs, D., Goldstein, G. and Hoffbrand, A. V., Use of anti-T cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet 1982. 1: 700-703.
13. Ferran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L. H., Grau, G., Bluestone, J., Bach, J. F. et al., Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 1990. 20: 509-515.
14. Gratama, J. W., Jansen, J., Lipovich, R. A., Tanke, H. J., Goldstein, G. and Zwaan, F. E., Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Clinical results and effect on circulating T lymphocytes. Transplantation 1984. 38: 469-474.
15. Martin, P. J., Hansen, J. A., Anasetti, C., Zutter, M., Durnam, D., Storb, R. and Thomas, E. D., Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies. Am. J. Kidney Dis. 1988. 11: 149-152.
16. Carpenter, P. A., Appelbaum, F. R., Corey, L., Deeg, H. J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J. et al., A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood 2002. 99: 2712-2719.
17. Cole, M. S., Anasetti, C. and Tso, J. Y., Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells. J. Immunol. 1997. 159: 3613-3621.
18. McEver, R. P. and Cummings, R. D., Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 1997. 100: 485-491.
19. Zimmerman, G. A., Two by two: the pairings of P-selectin and P-selectin glycoprotein ligand 1. Proc. Natl. Acad. Sci. USA 2001. 98: 10023-10024.
20. Borges, E., Eytner, R., Moll, T., Steegmaier, M., Campbell, M. A., Ley, K., Mossmann, H. and Vestweber, D., The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood 1997. 90: 1934-1942.
21. Flugel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H. and Wekerle, H., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001. 14: 547-560.
22. Li, B., New, J. Y., Yap, E. H., Lu, J., Chan, S. H. and Hu, H., Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur. J. Immunol. 2001. 31: 617-624.
23. 2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen. J. Immunol. 1997. 159: 5821-5833.
24. 2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. J. Immunol. 2001. 166: 5835-5839.
25. Anasetti, C., Tan, P., Hansen, J. A. and Martin, P. J., Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen. J. Exp. Med. 1990. 172: 1691-1700.
26. + T cells. Transplantation 1996. 61: 798-803.
27. Graca, L., Honey, K., Adams, E., Cobbold, S. P. and Waldmann, H., Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 2000. 165: 4783-4786.
28. Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J. and Waldmann, H., "Infectious" transplantation tolerance. Science 1993. 259: 974-977.
29. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
30. Cooke, A., Phillips, J. M. and Parish, N. M., Tolerogenic strategies to halt or prevent type 1 diabetes. Nat. Immunol. 2001. 2: 810-815.
31. Makhlouf, L., Grey, S. T., Dong, V., Csizmadia, E., Arvelo, M. B., Auchincloss, H., Jr., Ferran, C. and Sayegh, M. H., Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent auto-immune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 2004. 77: 990-997.
32. Maki, T., Ichikawa, T., Blanco, R. and Porter, J., Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc. Natl. Acad. Sci. USA 1992. 89: 3434-3438.
33. Chatenoud, L., Thervet, E., Primo, J. and Bach, J. F., Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 1994. 91: 123-127.
34. Levesque, J. P., Zannettino, A. C., Pudney, M., Niutta, S., Haylock, D. N., Snapp, K. R., Kansas, G. S., Berndt, M. C. and Simmons, P. J., PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity 1999. 11: 369-378.
35. Borges, E., Tietz, W., Steegmaier, M., Moll, T., Hallmann, R., Hamann, A. and Vestweber, D., P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J. Exp. Med. 1997. 185: 573-578.
36. Xia, L., Sperandio, M., Yago, T., McDaniel, J. M., Cummings, R. D., Pearson-White, S., Ley, K. and McEver, R. P., P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J. Clin. Invest. 2002. 109: 939-950.
37. Yang, J., Hirata, T., Croce, K., Merrill-Skoloff, G., Tchernychev, B., Williams, E., Flaumenhaft, R., Furie, B. C. and Furie, B., Targeted gene disruption monstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J. Exp. Med. 1999. 190: 1769-1782.